CLINICAL_TRIALS
trial_result
· 2024-05-03
Clinical Trial Update: Saracatinib Trial TO Prevent FOP [Phase 2]
Summary
A Phase 2 clinical trial evaluating saracatinib to prevent Fibrodysplasia Ossificans Progressiva is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amsterdam UMC, location VUmc | Conditions: Fibrodysplasia Ossificans Progressiva | Phase 2 | Status: RECRUITING